Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) 5-Year Yield-on-Cost %

: 5.38 (As of Today)

View and export this data going back to 2012. Start your Free Trial

Shanghai Fosun Pharmaceutical (Group) Co's yield on cost for the quarter that ended in Dec. 2023 was 5.38.

The historical rank and industry rank for Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:02196' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.64 Med: 1.59 Max: 5.56
Current: 5.38

During the past 13 years, Shanghai Fosun Pharmaceutical (Group) Co's highest Yield on Cost was 5.56. The lowest was 0.64. And the median was 1.59.

HKSE:02196's 5-Year Yield-on-Cost % is ranked better than
55.31% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.27 vs HKSE:02196: 5.38

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Fosun Pharmaceutical (Group) Co 5-Year Yield-on-Cost % Distribution

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Yield-on-Cost % falls into.

Shanghai Fosun Pharmaceutical (Group) Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Shanghai Fosun Pharmaceutical (Group) Co is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Shanghai Fosun Pharmaceutical (Group) Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) » Definitions » 5-Year Yield-on-Cost %

Traded in Other Exchanges

SFOSF:USA 08HH:Germany 600196:China

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Headlines

No Headlines